Abstract
This paper describes the development and validation of a reversed-phase HPLC method with isocratic conditions for the analysis of total cysteine in human plasma. The essential steps in the assay include derivatization of cysteine via thiol group with 2-chloro-1-methylpyridinium iodide (CMPI), separation of the formed cysteine S-pyridinium derivative from endogenous thiol derivatives, usually present in biological samples, by ion-pair reversed-phase HPLC, and ultraviolet detection. Free cystine and protein-bound cysteine are converted to their reduced counterpart by the use of 2-mercaptoethanol. The standard curve is linear over the concentration range from 20 to 300 nmol ml −1. The recoveries are from 93.9 to 105.9% and imprecision was at most 2.5%. Optimal conditions are determined for all steps of the analytical procedure.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
